Background/Aims: 3, 4, 5-trihydroxy-N-{4- [(5-methylisoxazol-3-yl) sulfamoyl] phenyl} benzamide (JEZTC), synthesized from gallic acid (GA) and sulfamethoxazole (SMZ), was reported with chondroprotective effects. However, the effects of JEZTC on osteoarthritis (OA) are still unclear. The goal of this study was to investigate the anti-osteoarthritic properties of JEZTC on interleukin-1-beta (IL-1β) stimulated chondrocytes in vitro and a rabbit anterior cruciate ligament transaction (ACLT) OA model in vivo. Methods: Changes in matrix metalloproteinases (MMPs) and apoptosis genes (bax, caspase 3 and tnf-α) and OA-specific protein (MMP-1) expression in vitro and in vivo were detected by real-time quantitative reverse transcriptionpolymerase chain reaction (qRT-PCR) and immunohistochemistry. The production of reactive oxygen species (ROS) were investigated upon the treatment of JEZTC in chondrocytes processed with IL-1β in vitro and OA in vivo. Effect of JEZTC on OA was further studied by the macroscopic and histological evaluation and scores. The key proteins in signaling pathways inMAPK/P38, PI3KAkt and NF-κB also determined using western blot (WB) analysis. Results: JEZTC could significantly suppress the expression of MMPs and intracellular ROS, while meaningfully increase the gene expression of tissue inhibitor of metalloproteinase-1 (TIMP-1). Moreover, there was less cartilage degradation in JEZTC group compared with the phosphatebuffered saline (PBS) group in vivo. Results also indicated that JEZTC exerts effect on OA by
IL-1β-induced chondrocytes and treatment
To investigate the effects of JEZTC and GA on IL-1β-induced chondrocytes, the cells were grouped as follow: (1) normal control group, chondrocytes treated with culture medium only; (2) IL-1β (OA model) group, chondrocytes treated with culture medium contained 10 ng/ml IL-1β (Gibco, USA); (3) JEZTC-1 group, chondrocytes pre-incubated with 2.344 µg/ml JEZTC for 1 h followed by stimulation with IL-1β for 24 h; (4) JEZTC-2 group, chondrocytes pre-incubated with 4.688 µg/ml JEZTC for 1 h followed by stimulation with IL-1β for 24 h; (5) JEZTC-3 group, chondrocytes pre-incubated with 9.376 µg/ml JEZTC for 1 h followed by stimulation with IL-1β for 24 h; (6) GA group, chondrocytes pre-incubated with 4.688 µg/ml GA for 1 h followed by stimulation with IL-1β for 24 h. The concentrations of JEZTC were determined according to previous study [26] . The dose of GA was derived from the preliminary cytotoxicity assay, which was optimal for cell growth.
OA induction and animal treatment
A total of twenty-four 12 weeks old male New Zealand white rabbits (Animal Centre of Guangxi Medical University, Guangxi, China) weighing 2.0-2.5 kg were used in this study. All experiments were conducted with the approval of the Guangxi Medical University Animal Care and Use Committee (2013-12-3) . Sixteen rabbits underwent bilateral anterior cruciate ligament transection (ACLT) on the knee joints to induce OA were randomly assigned to two groups. The other eight rabbits underwent sham operations (normal group), of which the articular cavity was opened and sutured without cutting the short anterior cruciate ligament. At 8 weeks after surgery, the JEZTC group received intra-articular injections of 0.5 ml JEZTC (4.688µg/ml, the dose exhibiting the best performance in the in vitro study) once per week for 8 weeks. The PBS (OA model) group was injected with 0.5 ml of PBS alone in both knees under the same conditions. In the sham-operation group, no other procedures were conducted.
Real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR) analysis
The mRNA expression of OA and apoptosis-specific gene was detected by qRT-PCR. For the in vitro study, cells were washed once with PBS and the total RNA was extracted using an RNA isolation kit (Tiangen Biotechnology; Beijing, China) according to the manufacturer's instructions. For the in vivo investigation, cartilage obtained at 4 and 8 weeks post-treatment was pulverized in liquid nitrogen before RNA extraction. Approximately 300 ng of total RNA was used as a template and reverse transcribed into cDNA using a reverse transcription kit (Fermentas Company, USA). The qRT-PCR reactions were performed using a Quantitative PCR Detection System (Realplex 4, Eppendorf Corporation, USA) with FastStart Universal SYBR Green Master (Mix, Roche company, Germany) and at the conditions of 10 min at 95°C, 15 s at 95°C and 1 min at 60°C. The primers used for PCR are shown in Table  1 . Each gene was analyzed in triplicate to diminish operation errors. The relative gene expression levels were calculated by using the 2 -ΔΔCt method and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) served as the internal reference. 
Macroscopic evaluation
After removal the soft tissue, macroscopic evaluation was performed by two observers (ZL, CL) at 4 and 8 weeks after treatment. The depth of erosion in articular cartilage were performed according to the criteria described by Pelletier et al. [34] using a four-grade scale (0 = a normal-appearing surface, 1= minimal fibrillation or a slight yellowish discoloration of the surface, 2 = erosion extending into the superficial or middle layers only, 3 = erosion extending into the deep layers, and 4= erosion extending to the subchondral bone). A higher score indicates greater cartilage damage.
Reactive oxygen species (ROS) assay
The production of reactive oxygen species (ROS) was assayed with an ROS detection reagent kit (Nanjing Jiancheng Bioengineering Research Institute, China) according to the manufacturer's instructions. Chondrocytes were treated with JEZTC or GA for 1h followed by IL-1β-stimulation for 24h, then washed twice with PBS and incubated with dichlorodihydrofluorescein diacetate (DCFDA, 10 μM) in PBS in the dark for 60 min. After washing with PBS, the fluorescence was measured immediately using a fluorescence microplate reader (FLx800, Biotek, USA) with excitation and emission at 485 and 525 nm, respectively. At 4 and 8 weeks post-treatment, cartilage homogenate was used to detect ROS generation under frozen conditions. After centrifugation, the supernatant was incubated with DCFDA, and the experiments were performed as previously described.
Histological examination
After macroscopic evaluation, the cartilage tissues were fixed in 4% paraformaldehyde and decalcified by buffered ethylenediaminetetraacetate (EDTA). Samples were embedded in paraffin and then cut into 3-μm sections. Paraffin sections were de-waxed and stained with hematoxylin-eosin (HE, JianCheng Biotech, China) and Masson (Fuzhou, Fujian, China) for histological examination and safranin O (Sigma, USA) for glycosaminoglycan (GAG) secretion orientation. Sections from each animal were randomized for histological evaluation to eliminate bias. Each section was scored separately by 3 independent researchers (ZL, HW and XL). The severity of the OA was graded using the histologic criteria (Table 2) according to Mankin et al, [35] based on structural changes (score range 0-6), cellular changes (score range 0-3), loss of safranin O staining (score range 0-4) and tidemark integrity (scored rang 0-1).
Immunohistochemistry
The evaluation of MMP-1 secretion was performed by an immunohistochemical staining kit (Bioss, China). Cells and de-waxed sections were washed in PBS and exposed to 3% H 2 O 2 for 15 min at room temperature to quench endogenous peroxidase activity. Then the cells were blocked with normal goat serum for 20 min at room temperature. After incubation overnight at 4°C with the primary antibody (1:200), the cells were incubated with the second antibody and biotin-labeled horseradish peroxidase. Subsequently, the antibody binding was visualized 
Western blot analysis
To prepare total protein from tissues and cells, cartilage obtained at 4 or 8 weeks after treatment in vivo was pulverized in liquid nitrogen and chondrocytes treated with JEZTC or GA followed by induction with IL-1β were washed with cool PBS, then lysis buffer (Sigma-Aldrich, USA) containing a protease inhibitor mixture was used for protein extraction. Equal amounts of protein (60 µg) were separated by SDS-polyacrylamide gel (Sigma, USA), and then transferred onto polyvinylidene fluoride (PVDF) membranes (Millipore, Billerica, MA, USA). PVDF membranes were blocked with 5% nonfat milk for 1h, and then incubated with primary antibodies (Abcam, UK) of P38(1:1000), p-P38 (1:800), Akt (1:500), p-Akt (1:1000), NF-κB (1:500) overnight at 4°C. The membranes were then incubated with the secondary antibody (Invitrogen, USA) and visualized using the Odyssey Infrared Imaging System (LI-COR, USA) according to the manufacturer's instructions. Data were normalized by housekeeping protein (GAPDH).
Statistical Analysis
Data were presented as the means ± SD. Significant differences were determined by one-way analysis of variance (ANOVA) followed by LSD post hoc test. The level of significance was set at P<0.05.
Results

Effects of JEZTC and GA on IL-1β-induced chondrocytes Effects of JEZTC and GA on the expression of MMPs and TIMP-1 in IL-1β-induced chondrocytes.
To investigate the effects of JEZTC and GA on OA, qRT-PCR was performed to determine the gene expression levels of MMP-1, MMP-3, MMP-13 and TIMP-1 in chondrocytes incubated with GA or JEZTC prior to stimulate with IL-1β. As shown in We next examined the effects of JEZTC and GA on the secretion of MMP-1 protein in IL-1β-induced chondrocytes using immunohistochemical analysis (Fig. 1C) . Treating with IL-1β resulted in the up-regulation of MMP-1 protein expression, as indicated by more intensely positive staining (dark brown staining) compared with normal control. JEZTC could down-regulate the secretion of MMP-1 protein, as demonstrated by the obviously lower positive staining. This was consistent with the results of qRT-PCR. Among the JEZTC groups, JEZTC-2 exhibited the lightest staining of MMP-1. In addition, the effect of GA is relatively weaker than JEZTC.
Effects of JEZTC and GA on IL-1β-induced ROS production. The influence of JEZTC and GA on intracellular ROS production in IL-1β-stimulated chondrocytes was also detected. Treating with IL-1β resulted in an increase of intracellular ROS generation to 59.0 ± 5.0 (Fig. 1B) . JEZTC significantly reduced intracellular ROS production by 9.5%, 26.2% and 19.1% in the JEZTC-1, JEZTC-2 and JEZTC-3 groups, respectively. However, this effect was much weaker in the GA group compared with JEZTC-treated groups.
Effect of JEZTC on articular cartilage Macroscopic observation. An OA experimental animal model of ACLT was used to evaluate the effects of JEZTC (JEZTC-2) on the development of tOA. After 8weeks of ACLT in rabbits, no meniscal tears were observed (data not showed). In the sham-operation (Normal) group, the cartilage on the femoral condyles was macroscopically normal, with a smooth, glistening surface, (Fig. 2A) . In the PBS group, general characteristics of OA, including erosion and osteophyte formation were seen on the side of the femoral condyles after 4 and 8 weeks post-treatment. The degree of cartilage destruction was increased over time.
The JEZTC group showed less bone wear than the PBS group as evidenced by gross appearance in the same period. Consistent with these findings, the macroscopic scores were reduced in the JEZTC group compared with the OA model group (Fig. 2B ) by 66% and 55.3% at 4 and 8 weeks post-treatment, respectively.
ROS generation in articular cartilage.
The levels of intracellular ROS generation in cartilage at 4 and 8 weeks post-treatment were detected by DCFDA probe (Beyotime, China). As shown in Fig. 2C , in the PBS group, ROS production increased in a time-dependent manner, by 21.4% and 64.6% at 4 and 8 weeks, respectively. However, JEZTC effectively reduced the intracellular ROS production by 8.9% and 46.2% at 4 and 8 weeks, respectively. Histological changes in articular cartilage. Histological changes in the cartilage after surgery mainly involved the thinner cartilage layer, abraded surface and reduced safranin O depositing in the cartilage. In the PBS group, extensive degeneration of cartilage was observed, as illustrated by a mass of superficial layer loss, the general disappearance of chondrocytes (Fig. 3A) and the loss of GAG (Fig. 3B) from the femoral condyle. The cartilage in PBS group exhibited much greater destruction at week 8 compared to week 4. Nevertheless, the cartilage destruction was significantly diminished in the treatment of JEZTC which prevented damage to the cartilage structure, reduced cellular abnormalities, and preserved matrix architecture. However, osteophyte proliferation could not be reversed (Fig. 3A-C) . The Mankin score was used to further evaluate the cartilage damage. Overall, the Mankin scores were lower in the JEZTC group at 4 and 8 weeks post-treatment compared with the PBS group ( Fig. 3D and E) , these was consistent with the macroscopic findings (Fig. 2B) . (Fig. 4A and B) . These results suggested that In specimens of cartilage from the femoral condyle of normal rabbits, chondrocytes within the superficial layers were stained positive for MMP-1, which plays a key role in the progression of OA. In the PBS group, greater numbers of MMP-1-positive cells were detected in the middle and deep cartilage layers compared with normal cartilage, indicating extensive destruction of cartilage. However, in the JEZTC group, only a small number of positive cells were observed in the shallow and middle cartilage layers and most of the cartilage tissue remained intact (Fig. 3C) .
Anti-arthritic effect of JEZTC on IL-1β-induced chondrocytes and cartilage via the MAPK, NF-κB and PI3K/Akt signaling pathways
To explore the molecular mechanisms of JEZTC inhibited IL-1β-induced destruction in chondrocytes and OA, we investigated the involvement of the MAPK, NF-κB and PI3K/Akt signaling pathways using western blot analysis. In the in vitro study, IL-1β-induced increased of phospho-P38/P38 (p-P38/P38), phospho-Akt/Akt (p-Akt/Akt) and NF-κB expression were diminished by JEZTC in a dose-dependent manner (Fig. 5B) . Moreover, among the JEZTC groups, the greatest reduction of related proteins expression in JEZTC-2 group was superior to the JEZTC-1 and JEZTC-3 groups.
The in vivo investigation was consistent with the results in vitro. JEZTC significantly down- 
Discussion
Drug therapy is among the most typical choices for the treatment of OA. GA, which can suppress the expressions of pro-inflammatory cytokines and chemokines have been widely studied [21] [22] [23] . IL-1 is a pivotal cytokine in many inflammatory disorders including OA, which induces MMPs and TIMP-1 involved in cartilage degradation in vitro. In our in vitro study, we found that JEZTC ameliorated IL-1β-induced chondrocytes destruction by inhibiting the expression of MMP-1, MMP-3 and MMP-13 as well as up-regulating the expression of TIMP-1 (Fig.  1A) . MMP-3 protein was reported to be expressed in the synovium and the surface of cartilage in the knee joints and pannus-like tissue of patients with OA [36] . Among the MMPs, MMP-1 and MMP-13 are interstitial collagenases mainly responsible for type II collagen degradation, which is a committed step in the progression of OA [37] . It has been suggested that inhibition of IL-1 induced MMPs expression may benefit for chondro-protection on the pathological conditions [38] , which was further demonstrated in in vivo investigation.
The effect of JEZTC on cartilage degradation in vivo was investigated in an ACLT-based experimental model of OA．This model is a well-established animal model of OA and has been widely used to evaluate the efficacy of agents in the treatment of OA. ACLT in the rabbit resulted in cartilage degradation due to the mechanical instability [39] . As evidenced by the improvement in macroscopic and histopathologic scores, injection of JEZTC for 4 and 8 weeks obviously improved the structure of the injured joints thereby alleviating the development of OA ( Fig. 2A  and B, Fig. 3 ). More specifically, the impact of JEZTC on the development of OA was manifested by a decrease in the OA-specific gene expression of MMP-1, MMP-3 and MMP-13 and an increase in TIMP-1 expression in animals treated with JEZTC ( Fig. 4A and B) . The results were in consistence with the in vitro findings (Fig. 1A) which indicated the beneficial effects of JEZTC on protection of cartilage degradation both in vitro and in vivo.
Analysis of the molecular mechanisms revealed that several signaling pathways are involved in the anti-arthritis effects of JEZTC, including MAPK, NF-κB and PI3K/Akt signaling pathways, which are known to play major roles in the biomechanical and metabolic pathways involved with the etiology and pathogenesis of OA [40, 41] . NF-κB is abundant in inflamed tissue and contributes to the progression of extracellular matrix damage and cartilage destruction [42] . During the process of OA, the cytokines, such as IL-1, activate the NF-κB dimers by triggering a signaling pathway that leads to the phosphorylation of IkB. Once phosphorylated, IκBs undergo poly-ubiquitination and ultimately proteosomic degradation, allowing NF-κB to enter the nucleus and promote the transcription of inflammatory genes like TNF-α and IL-1β [43] . The results showed that JEZTC markedly inhibited the activation of NF-κB, as evidenced by the downregulation of the expression of NF-κB both in vitro (Fig. 5B) and in vivo (Fig. 6B) . These indicate that JEZTC may down-regulate the expression of MMPs via the inactivation of NF-κB signaling pathway.
P38/ MAPK is part of an intracellular signaling pathway activated by proinflammatory cytokines and environmental stressors including IL-1 and TNF-α which have been linked to pathogenesis od OA [44] [45] [46] [47] . In OA model, the level of phosphorylated MAPKs, including extracellular signal regulated kinase (ERK) and p38 appears to be higher than that in normal cartilage [48] , these was in agreement with our study (Fig. 5 B and 6B) . However, the activity of P38 was decreased in cells treated with JEZTC in a dose-dependent manner. Further study showed that P38 was significantly down-regulated by JEZTC in OA model, suggesting the role of JEZTC in the regulation of p38 MAPK signaling pathway (Fig. 5A and 6B ) to block OA.
The PI3K/AKT signaling pathway also plays an important role in OA [49] . PI3K and phosphorylated Akt act as survival signals in preventing TNF-α-induced apoptosis [50, 51] . In this study, the results showed that the p-AKT increased significantly in IL-1β induced in vitro model and in vivo OA model (Fig. 5A and 6B ). In the treatment of JEZTC, the expression of p-AKT was significantly down-regulated in a dose-dependent. It indicates that JEZTC inhibits the production of inflammatory mediators in OA, which may be mediated partly through suppression of the PI3K/AKT pathway or MAPK cascades, leading to inactivation of NF-κB.
Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry ROS are toxic and play an important role in the initiation and pathophysiology of OA [52] . Intracellular ROS can also mediate destroy and degradation of the extracellular matrix by causing of chondrocytes apoptosis in cartilage [53, 54] . As a strong antioxidant and anti-inflammatory agent, GA was found to attenuate ROS release to prevent OA progression [55] , which was in agreement with our study. However, GA has much weaker effect than JEZTC (Fig. 1B and Fig. 2C ). Our previous study showed that GA derivatives had stronger anti-oxidant effects than GA [29] [30] [31] [32] [33] 55] , which may be due to that GA is much more hydrophilic and cytotoxic than its esters [14] .
Conclusion
In summary, we investigated the protective effects of JEZTC on IL-1β-stimulated chondrocytes in vitro and OA in vivo. The inhibition of MMPs by JEZTC was associated in part with inhibition the PI3K/AKT, p38/MAPK and NF-κB signaling pathways. Our results indicate that JEZTC may be a promise therapeutic agent for the treatment of OA.
However, these preliminary findings in anti-osteoarthritic effect of JEZTC were only affirmed on the cell and animal level, further clinical studies are needed to confirm and extend.
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